PFTR.OB Insider Trading Activity and SEC Form 4 Filings
PFTR.OB insider trading summary
No open-market insider purchases or sales of PharmaFrontiers Corp. (PFTR.OB) have been reported on SEC Form 4 in the past 12 months.
Latest PFTR.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 14, 2005 | William Rouse | CFO | Buy | $975 (1,500 @ $0.65) |
| Dec 14, 2005 | David McWilliams | CEO | Buy | $1K (2,000 @ $0.63) |
| Dec 1, 2005 | Tony Kamin | Director | Buy | $3K (5,000 @ $0.69) |
| Jul 18, 2005 | David McWilliams | CEO | Buy | $0 (23,334 @ $0.00) |
| Apr 27, 2005 | Warren C Lau | Insider | Sell | $72K (36,000 @ $2.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.